The best stocks to buy since 1993

Latest issue now available


October 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ERGO
  • Price:
  • 1320p
Finance director Richard Barfield was in good cheer when we caught up post the H1 results. Ergomed reported an order book +18% to £228m (+21% at constant currency) and the book-to-bill ratio is running at 1.6 so Ergomed is clearly growing and has huge 85-90% visibility for H2 with one quarter yet to go - and this is based on recently upgraded forecasts, which went to  £23.4m pretax/£24.2m ebitda/eps 28.3p.As it was, H1 showed sales up 39% to £56m (+18% like-for-like), ebitda of £12.6m and eps of 16.8p - so a ‘beat’ looks inevitable. Within the mix, PrimeVigilance was +16% to £28.8m, continuing its steady high growth whilst CRO, which has most of its work in oncology/rare diseases ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X



To access our archive of articles and to receive current issues you need to subscribe